Author:
Ozge Gokhan,Kucukevcilioglu Murat,Koylu Mehmet Talay
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference11 articles.
1. Prete M, Dammacco R, Fatone MC, Racanelli V. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. Clin Exp Med. 2015. doi: 10.1007/s10238-015-0345-6
2. Ayyıldız O, Durukan AH, Ozgurtas T, Gunal A. A Comparison of intravitreal bevacizumab and steroid activity in an experimental uveitis model. Curr Eye Res. 2015;40(12):1261–8.
3. Egwuagu CE, Sun L, Kim SH, Dambuza IM. Ocular inflammatory diseases: molecular pathogenesis and ımmunotherapy. Curr Mol Med. 2015;15(6):517–28.
4. Tomkins-Netzer O, Lightman S, Drye L, Multicenter Uveitis Steroid Treatment Trial Research Group, et al. Outcome of treatment of uveitic macular edema: the multicenter uveitis steroid treatment trial 2-year results. Ophthalmology. 2015;122(11):2351–9.
5. Lardenoye CWTA, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113(8):1446–9.